Risk of both ischemic stroke and coronary heart disease was elevated with high triglycerides and low high-density lipoprotein cholesterol.
The new guidelines call for treating low-density lipoprotein cholesterol in specific patient groups to lower goals than previously recommended.
Too few American young adults are receiving needed statin medications, according to findings published in JAMA Cardiology.
Fenofibrate therapy may reduce cardiovascular disease (CVD) in statin-treated patients with diabetes and dyslipidemia.
Women and minorities with HIV are less frequently tested for dyslipidemia, according to a new study from IDWeek 2016.
Even if the impact of a given medication on lipid profile is relatively minimal, and therefore unlikely to independently affect ASCVD risk, the cumulative effect is important and cannot be overlooked.
Blacks have increased incidence of hypertension, diabetes, and dyslipidemia but not atrial fibrillation.
Having both diseases raises a patient's chances for developing diabetes.
Serum 25-hydroxyvitamin D levels correlated with risk for dyslipidemia.
Adolescents with autism spectrum disorder appear to be more likely to develop the disease.
Follicle-stimulating hormone may interact with its receptors and lead to elevated LDL cholesterol in postmenopausal women.
Researchers noted an improvement in lipid profile for nutraceuticals alone or in combination in statin-intolerant patients.
Key features include elimination of treatment targets and additional testing only when rationale clear.
Findings in older men with high cholesterol and low testosterone.
Researchers have discovered that a common medication indicated for the treatment of high cholesterol may stimulate the same peroxisome proliferator-activated receptors (PPARs) as cannabinoids, which could lead to a new class of cannabis-like drugs to treat a range of conditions.
An increasingly sedentary lifestyle has been linked to coronary calcification, regardless of exercise or traditional risk factors.
Many patients with diabetes may not be adhering to medication regimens and are therefore experiencing higher rates of cardiac events.
About half of extremely obese children had elevated blood pressure or dyslipidemia.
Recommendations based on existing guidelines for general population; many gaps in knowledge.
About one in five had dyslipidemia; one in ten had high or borderline BP in 2011 to 2012.
Overweight or obese adults with risk cardiovascular disease risk factors should be referred for intensive behavioral counseling.
Endocrinology Advisor Articles
- Semaglutide Improved Beta-Cell Function and Glycemic Control in Type 2 Diabetes
- Blood Glucose Self-Monitoring in Type 2 Diabetes Does Not Benefit Glycemic Control
- Elagolix Relieves Short-Term Menstrual Pain, Dysmenorrhea in Endometriosis
- Improving Glycemic Control in T2D With Text Message Intervention
- The Handoff: Your Week in Endocrinology News - 6/23/17
- Reduced Cardiovascular Events in Type 2 Diabetes Treated With Dapagliflozin
- Prolonged Delayed Eating Linked to Weight Gain, Increased Respiratory Quotient
- Canagliflozin Reduces Cardiovascular Stress In Older Patients With Type 2 Diabetes
- GLP-1 Analog Counteracts Antipsychotic-Induced Glucose Intolerance, Weight Gain
- Diabetic Retinopathy Caused by Sleep Apnea in T2D
- USPSTF Updates Recommendations for Screening Obesity in Children and Adolescents
- Exercise Protocol Improves Outcomes in T2D
- Interspersed Upper Body Activity With Sedentary Time Improves Glucose, Insulin
- AHA Advisory: Replace Saturated Fat to Reduce CVD By 30%
- Type 2 Diabetes Death and CV Events Predicted by Systolic Blood Pressure Variability